KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcosa (ACA) Shares Outstanding (Weighted Average) (2017 - 2025)

Arcosa's Shares Outstanding (Weighted Average) history spans 9 years, with the latest figure at $48.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 0.62% year-over-year to $48.9 million; the TTM value through Dec 2025 reached $48.9 million, up 0.62%, while the annual FY2025 figure was $48.9 million, 0.62% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $48.9 million at Arcosa, roughly flat from $49.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $49.0 million in Q3 2025 and bottomed at $48.0 million in Q2 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $48.5 million (2023), against an average of $48.5 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) rose 0.83% in 2023 before it changed 0.0% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $48.1 million in 2021, then grew by 0.21% to $48.2 million in 2022, then increased by 0.62% to $48.5 million in 2023, then increased by 0.21% to $48.6 million in 2024, then grew by 0.62% to $48.9 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's Shares Outstanding (Weighted Average) are $48.9 million (Q4 2025), $49.0 million (Q3 2025), and $48.9 million (Q2 2025).